Nonmyeloablative, HLA-Haploidentical Bone Marrow Transplantation with High Dose, Post-Transplantation Cyclophosphamide
Ashley Munchel(Johns Hopkins University), Ephraim J. Fuchs(Johns Hopkins Hospital), Heather J. Symons(Johns Hopkins University), Yvette L. Kasamon(Johns Hopkins University), Chimen Kesserwan(Johns Hopkins University), Leo Luznik(Sidney Kimmel Comprehensive Cancer Center), Richard J. Jones(Sidney Kimmel Cancer Center)
Cited by 84
Related Papers
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
B Cells Turn Off Virgin But Not Memory T Cells
|Science|1992|570
Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation
|Cancer Chemotherapy and Pharmacology|1989|406